Aerogen Lands in India Elevating Respiratory Care, One Breath at a Time

Aerogen has established a full-scale base in India to expedite the adoption of their vibrating-mesh nebuliser technology in the South Asian market. They expanded in a rapidly growing country in healthcare sector and makes it possible for quicker deployment, clinical partnerships, and regional expansion into nearby nations for Aerogen.

• Minister of Higher Education, Research, and Innovation, Ireland, James Lawless, in March 2025 inaugurated the Aerogen Indian headquarters in Delhi.

Hon. Minister of Higher Education, Research, and Innovation, Ireland, James Lawless said, "This milestone reinforces our shared commitment to healthcare innovation and strengthens the ties between India and Ireland." Aerogen's choice to open a location in India is evidence of the nation's quickly developing healthcare sector. We are eager to develop a borderless business where India and Ireland gain from bilateral cooperation in research and innovation.”

Why It Matters

• In India over 55 million people suffer from chronic obstructive pulmonary disease (COPD) and the number of respiratory ailments is on the rise. Advanced aerosol technologies from Aerogen provide better clinical results and medicine delivery.
• Aerogen system is different from older jet or nebulizer systems in that vibrating-mesh nebulisers generate finer aerosol particles, and it allows for deeper, more effective deposition in the lungs are a vital aspect of critical care unit treatment.
• The shorter nebulisation durations decreased drug waste, and a decreased risk of nosocomial infections contributes to improved patient outcomes and more efficient workflows.

Hannah Yuill, Senior Commercial Director APAC said, “Aerogen is committed to providing the most cutting-edge aerosol medicine delivery technologies to Indian hospitals and patients. Given the size of India's population and the rising incidence of respiratory illnesses, our growth is essential to helping the country's healthcare system provide high-quality patient treatment in a safe and efficient manner. This investment in India is an essential component of our plan to grow throughout the Asia-Pacific area and work closely with medical experts to enhance the results of respiratory treatment.”

Paving the Future Way for Respiratory Care Across Borders

• Deepening footprint: This represents growing international investments in India as a Medtech hub and is Aerogen's second significant APAC footprint after expansion in Southeast Asia.
• The Future pathway: The expansion of Aerogen in the country will boost many investments in partnerships, training and research to expand access to its advanced aerosol drug delivery technology in the country. The company aims to transform respiratory care and strengthen regional healthcare outcomes with collaborating with leading clinicians and institutions in India and Sri Lanka.

“Aerogen is in the forefront of the MedTech sector in Ireland, which is a global leader in this field. Their expansion in the country shows their commitment to enhancing respiratory care worldwide as well as the growing business and economic relationship between Ireland and India. We are honoured to assist Aerogen in their mission to significantly improve healthcare around the world.” said, Ross Curran, Director - India & South Asia, Enterprise Ireland.